Epidemiological update: Measles among asylum seekers in Germany, 10 August 2016
On 8 August 2016, the Robert Koch Institute in Berlin published an overview of measles cases reported from asylum seeker centres in Germany over the period January to July 2016
Risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
At the request of the European Commission’s Directorate-General for Health and Consumers, a rapid risk assessment has been prepared concerning the outbreak of E Coli in Germany.
Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104
This joint report, produced by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA), aims to give a short summary of reported Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) prevalence and incidence in humans, food and animals.
Outbreak of Shiga toxin-producing E. coli (STEC) in Germany, May 2011
Shiga toxin-producing E. coli (STEC) is a group of pathogenic Escherichia coli strains capable of producing Shiga toxins, with the potential to cause severe enteric and systemic disease in humans.
Revised risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
An update of the initial rapid risk assessment on the outbreak of E. Coli in Germany, prepared at the request of the European Commission, first published on 27 May 2011.
Epidemiological update: Measles - monitoring European outbreaks, 6 April 2017
In Europe, measles cases have been reported in Austria, Belgium, Bulgaria, Denmark, France, Germany, Hungary, Iceland, Italy, Portugal, Spain and Sweden as well as in Romania, where 4 025 cases have been reported as of 31 March 2017.
Risk assessment: New Orthobunyavirus isolated from infected cattle and small livestock ─ potential implications for human health
Based on current evidence, it is not possible to confirm or exclude a causal relationship between detection of the new orthobunyavirus and the observed clinical symptoms in cattle and small livestock.
Joint risk assessment: New Orthobunyavirus isolated from infected cattle and small livestock ─ potential implications for human health
This updated rapid risk assessment was prepared jointly with the Robert Koch Institute (RKI), Germany, and the National Institute of Public Health and the Environment (RIVM), Netherlands.
Joint rapid risk assessment: Anthrax cases among injecting drug users, Germany, 22 June 2012
Following reports of two cases of anthrax among injecting drug users in Germany, ECDC and EMCDDA jointly prepared a rapid risk assessment.
Rapid risk assessment: Anthrax cases among injecting drug users - Germany, June-July 2012 - Update, 6 July 2012
This is an update to the joint rapid risk assessment published on 22 June 2012 by ECDC and EMCDDA on anthrax cases among injecting drug users in Germany. This is in response to a third case in Berlin. It contains information updated up to the 6 July 2012.